Stage IV Adult Immunoblastic Large Cell Lymphoma Completed Phase 1 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0028715 (Stage IV Adult Immunoblastic Large Cell Lymphoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00010192Rituximab Plus Interleukin-2 in Treating Patients With Hematologic CancerTreatment